港股異動 | 中國平安(02318.HK)創近三個月新高 第二大海外中國股基大舉增持
格隆匯1月20日丨中國平安(02318.HK)漲逾4%,報63.95港元創近三個月新高;中國平安(601318.SH)亦漲2.49%。第二大海外中國股票基金摩根基金-中國A股機遇A(累計)-人民幣於2021年12月大幅增持中國平安,增持幅度達42.84%。國信證券發佈研究報吿稱,12月以來,多家壽險企業暫停開展互聯網保險業務,相關的多款網紅保險產品已經下架。同時,部分網紅產品更新換代,有的更換承包商重新上市。在互聯網保險新政的發酵下,行業格局勢必變化,大中型企業的市場份額會逐步提升,中國平安等大型壽險企業的市場份額或有望穩定。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.